期刊
BRAIN SCIENCES
卷 11, 期 11, 页码 -出版社
MDPI
DOI: 10.3390/brainsci11111487
关键词
Alzheimer's disease; Dihexa; cognitive; PI3K/AKT
资金
- National Natural Science Foundation of China [81771140]
- Youth Medical Talent Program of Jiangsu Province [QNRC2016068]
- Medical Innovation Team of Jiangsu Province [CXTDA2017030]
The study revealed that Dihexa can restore AngIV levels in the brain tissues of APP/PS1 mice by activating the PI3K/AKT signaling pathway, reducing inflammation, and increasing anti-inflammatory cytokine levels, thereby improving cognitive function and spatial learning. This suggests that the brain AngIV/PI3K/AKT axis may be a potential target for the treatment of AD.
The renin-angiotensin system (RAS) is a paracrine RAS within the central nervous system (CNS) and is closely related to Alzheimer's disease (AD). The endogenous hexapeptide angiotensin IV (Ang IV), an important component of the brain RAS, was found to rescue cognitive impairment and recover memory in previous studies. In our study, we used different doses of Dihexa, which can be orally administered and cross the BBB in APP/PS1 mice. We found that the amount of AngIV in mouse tissue increased after the administration of Dihexa compared to that in the WT group. Meanwhile, Dihexa restored spatial learning and cognitive functions in the Morris water maze test. Dihexa increased the neuronal cells and the expression of SYP protein in APP/PS1 mice in Nissl staining. Furthermore, Dihexa decreased the activation of astrocytes and microglia, markedly reduced levels of the pro-inflammatory cytokines IL-1 beta and TNF-alpha and increased the levels of the anti-inflammatory cytokine IL-10. Dihexa activated the PI3K/AKT signaling pathway, while PI3K inhibitor wortmannin significantly reversed the anti-inflammatory and anti-apoptotic effects of APP/PS1 mice. These findings highlight the brain AngIV/PI3K/AKT axis as a potential target for the treatment of AD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据